PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-22

Date Title Company
22-Nov-2024 Comment on withdrawn non-binding offer Evotec SE
22-Nov-2024 Eckert & Ziegler raises its forecast for the current financial year once again Eckert & Ziegler SE
22-Nov-2024 Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment AccessWire
22-Nov-2024 Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) AccessWire
22-Nov-2024 Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024 AccessWire
22-Nov-2024 Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs AccessWire
22-Nov-2024 Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting AccessWire
22-Nov-2024 Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm AccessWire
22-Nov-2024 Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission Drägerwerk AG & Co. KGaA
22-Nov-2024 Frequency Exchange Welcomes Former NHL Star and Current President of the Boston Bruins Cam Neely to Its Advisory Board AccessWire
22-Nov-2024 Sunshine Biopharma Launches a New Generic Prescription Drug AccessWire
22-Nov-2024 Protagonist Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference 2024 AccessWire
22-Nov-2024 Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR LondonValves 2024 Meril Life Sciences
22-Nov-2024 Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA Sartorius Stedim Biotech
22-Nov-2024 Vetter Strengthens Senior Management Team for Further Sustainable Growth Vetter
22-Nov-2024 Scientists can predict how long prostate cancer patients will respond to olaparib The Institute of Cancer Research
22-Nov-2024 HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan HUTCHMED
22-Nov-2024 Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial AccessWire
22-Nov-2024 Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the third quarter of 2024 Vita 34 AG
22-Nov-2024 Modular Medical Announces Pricing of $8.2 Million Public Offering AccessWire